We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+17.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$74.4M
AUM Growth
-$7.7M
Cap. Flow
-$18.3M
Cap. Flow %
-24.64%
Top 10 Hldgs %
31.3%
Holding
122
New
27
Increased
23
Reduced
27
Closed
36

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$1.5M
2
NOW icon
ServiceNow
NOW
+$1.34M
3
DXC icon
DXC Technology
DXC
+$1.33M
4
MSFT icon
Microsoft
MSFT
+$1.31M
5
AMZN icon
Amazon
AMZN
+$1.27M

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$2.44M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.3M
3
BIIB icon
Biogen
BIIB
+$2.15M
4
WFT
Weatherford International plc
WFT
+$2.13M
5
CSC
Computer Sciences
CSC
+$2.05M

Sector Composition

Rank Sector Weight
1 Healthcare 39.18%
2 Technology 15.24%
3 Consumer Discretionary 6.1%
4 Communication Services 4.55%
5 Financials 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
51
Apple
AAPL
$4.46T
$426K 0.57%
11,820
-9,256
-44% -$342K
PBYI icon
52
CALL
Puma Biotechnology
PBYI
$391M
$420K 0.56%
+4,800
New +$269K
ICLR icon
53
Icon
ICLR
$12.2B
$418K 0.56%
4,272
-1,746
-29% -$154K
BMRN icon
54
BioMarin Pharmaceuticals
BMRN
$11.6B
$361K 0.49%
3,973
-17,991
-82% -$1.64M
MYOK
55
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$359K 0.48%
27,370
-3,587
-12% -$47.3K
CHRS icon
56
Coherus Oncology
CHRS
$222M
$348K 0.47%
24,236
+8,027
+50% +$154K
ZEN
57
DELISTED
ZENDESK INC
ZEN
$340K 0.46%
+12,254
New +$336K
BKNG icon
58
Booking.com
BKNG
$149B
$329K 0.44%
+4,400
New +$323K
NVDA icon
59
NVIDIA
NVDA
$5.01T
$328K 0.44%
+90,760
New +$288K
VMC icon
60
Vulcan Materials
VMC
$36.7B
$315K 0.42%
2,488
– –
TREE icon
61
LendingTree
TREE
$448M
$273K 0.37%
+1,584
New +$238K
ARAY icon
62
Accuray
ARAY
$32.2M
$247K 0.33%
51,928
-1,006
-2% -$4.42K
MMSI icon
63
Merit Medical Systems
MMSI
$5.11B
$233K 0.31%
+6,108
New +$204K
HRC
64
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$229K 0.31%
+2,873
New +$217K
KURA icon
65
Kura Oncology
KURA
$816M
$212K 0.28%
22,796
-694
-3% -$6.32K
EVH icon
66
Evolent Health
EVH
$353M
$202K 0.27%
7,967
-2,168
-21% -$52.1K
RXDX
67
DELISTED
Ignyta, Inc.
RXDX
$199K 0.27%
+19,254
New +$156K
XENT
68
DELISTED
Intersect ENT, Inc
XENT
$196K 0.26%
7,011
+4,807
+218% +$109K
CSII
69
DELISTED
Cardiovascular Systems, Inc.
CSII
$194K 0.26%
6,020
-3,281
-35% -$100K
ESPR
70
DELISTED
Esperion Therapeutics
ESPR
$186K 0.25%
+4,023
New +$148K
ALDR
71
DELISTED
Alder Biopharmaceuticals
ALDR
$175K 0.24%
15,296
-6,509
-30% -$120K
VYGR icon
72
Voyager Therapeutics
VYGR
$181M
$147K 0.2%
16,417
-17,726
-52% -$178K
EVHC
73
DELISTED
Envision Healthcare Holdings Inc
EVHC
$132K 0.18%
+2,100
New +$121K
JNCE
74
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$100K 0.13%
7,095
+1,611
+29% +$34.5K
RGNX icon
75
Regenxbio
RGNX
$638M
$95K 0.13%
4,824
-11,453
-70% -$222K
1 2
3
4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Partner Investment Management held 122 positions worth $74.4M, down 9.4% from $82.1M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Partner Investment Management withdrew a net $18.3M in Q2 2017, closing 36 positions and reducing 27 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Partner Investment Management opened a new position in McKesson worth $1.63M.

  • Partner Investment Management's largest Q2 2017 buy was McKesson: 9,888 shares worth $1.63M.
  • Partner Investment Management added most to Microsoft in Q2 2017, an estimated $1.31M increase.
  • Partner Investment Management's biggest Q2 2017 reduction was Marvell Technology, cutting an estimated $2.44M.
  • Partner Investment Management fully exited Jazz Pharmaceuticals in Q2 2017, selling an estimated $2.3M.
  • Partner Investment Management's ten largest holdings make up 31% of its $74.4M portfolio in Q2 2017.
  • Partner Investment Management opened 27 new positions and closed 36 in Q2 2017.
  • Partner Investment Management's portfolio value fell 9.4% quarter-over-quarter to $74.4M.

Based on Partner Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.